EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
Harvard Apparatus Regenerative Technology, Inc. (HRGN) had EBIT Margin of -775.34% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$0.22M |
|
$-1.69M |
|
$0.20M |
|
$0.02M |
|
$1.92M |
|
$-1.70M |
|
$-0.02M |
|
$-1.69M |
|
$-1.69M |
|
$-1.69M |
|
$-1.69M |
|
$-1.69M |
|
$-1.69M |
|
$-1.70M |
|
$-1.67M |
|
16.52M |
|
16.52M |
|
$-0.11 |
|
$-0.11 |
|
| Balance Sheet Financials | |
$1.83M |
|
$0.01M |
|
$0.85M |
|
$2.68M |
|
$1.53M |
|
-- |
|
$0.09M |
|
$1.62M |
|
$1.06M |
|
$1.06M |
|
$1.06M |
|
17.58M |
|
| Cash Flow Statement Financials | |
$-3.83M |
|
-- |
|
$2.70M |
|
$2.49M |
|
$1.35M |
|
$-1.13M |
|
$2.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.19 |
|
-- |
|
-- |
|
-- |
|
-- |
|
9.13% |
|
-775.34% |
|
|
EBIT Margin |
-775.34% |
-- |
|
-770.32% |
|
-770.32% |
|
$-3.83M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
12.44 |
|
13.69 |
|
6.58 |
|
-159.60% |
|
-159.60% |
|
-63.02% |
|
-159.60% |
|
$0.06 |
|
$-0.23 |
|
$-0.23 |
|